CPHI
Price
$0.24
Change
-$0.01 (-4.00%)
Updated
Apr 3 closing price
Capitalization
18.31M
PAHC
Price
$20.22
Change
-$1.68 (-7.67%)
Updated
Apr 3 closing price
Capitalization
523.71M
33 days until earnings call
Ad is loading...

CPHI vs PAHC

Header iconCPHI vs PAHC Comparison
Open Charts CPHI vs PAHCBanner chart's image
China Pharma Holdings
Price$0.24
Change-$0.01 (-4.00%)
Volume$341.72K
Capitalization18.31M
Phibro Animal Health
Price$20.22
Change-$1.68 (-7.67%)
Volume$246.06K
Capitalization523.71M
CPHI vs PAHC Comparison Chart
Loading...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPHI vs. PAHC commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPHI is a StrongBuy and PAHC is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (CPHI: $0.24 vs. PAHC: $20.22)
Brand notoriety: CPHI and PAHC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CPHI: 37% vs. PAHC: 87%
Market capitalization -- CPHI: $18.31M vs. PAHC: $523.71M
CPHI [@Pharmaceuticals: Other] is valued at $18.31M. PAHC’s [@Pharmaceuticals: Other] market capitalization is $523.71M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPHI’s FA Score shows that 0 FA rating(s) are green whilePAHC’s FA Score has 2 green FA rating(s).

  • CPHI’s FA Score: 0 green, 5 red.
  • PAHC’s FA Score: 2 green, 3 red.
According to our system of comparison, PAHC is a better buy in the long-term than CPHI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPHI’s TA Score shows that 4 TA indicator(s) are bullish while PAHC’s TA Score has 3 bullish TA indicator(s).

  • CPHI’s TA Score: 4 bullish, 4 bearish.
  • PAHC’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CPHI is a better buy in the short-term than PAHC.

Price Growth

CPHI (@Pharmaceuticals: Other) experienced а -17.74% price change this week, while PAHC (@Pharmaceuticals: Other) price change was -6.73% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.00%. For the same industry, the average monthly price growth was -2.21%, and the average quarterly price growth was -10.30%.

Reported Earning Dates

CPHI is expected to report earnings on May 18, 2023.

PAHC is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.00% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PAHC($524M) has a higher market cap than CPHI($18.3M). CPHI YTD gains are higher at: 2.710 vs. PAHC (-3.232). CPHI has less debt than PAHC: CPHI (5.39M) vs PAHC (513M).
CPHIPAHCCPHI / PAHC
Capitalization18.3M524M3%
EBITDAN/A83.7M-
Gain YTD2.710-3.232-84%
P/E RatioN/A34.11-
RevenueN/A982M-
Total CashN/A92.5M-
Total Debt5.39M513M1%
FUNDAMENTALS RATINGS
CPHI vs PAHC: Fundamental Ratings
CPHI
PAHC
OUTLOOK RATING
1..100
766
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9878
PRICE GROWTH RATING
1..100
4345
P/E GROWTH RATING
1..100
10025
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (22) in the Pharmaceuticals Major industry is in the same range as CPHI (45) in the Pharmaceuticals Generic industry. This means that PAHC’s stock grew similarly to CPHI’s over the last 12 months.

PAHC's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as CPHI (100) in the Pharmaceuticals Generic industry. This means that PAHC’s stock grew similarly to CPHI’s over the last 12 months.

PAHC's SMR Rating (78) in the Pharmaceuticals Major industry is in the same range as CPHI (98) in the Pharmaceuticals Generic industry. This means that PAHC’s stock grew similarly to CPHI’s over the last 12 months.

CPHI's Price Growth Rating (43) in the Pharmaceuticals Generic industry is in the same range as PAHC (45) in the Pharmaceuticals Major industry. This means that CPHI’s stock grew similarly to PAHC’s over the last 12 months.

PAHC's P/E Growth Rating (25) in the Pharmaceuticals Major industry is significantly better than the same rating for CPHI (100) in the Pharmaceuticals Generic industry. This means that PAHC’s stock grew significantly faster than CPHI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPHIPAHC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 9 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
71%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSEX66.572.70
+4.23%
Middlesex Water Company
YMAB4.66-0.14
-2.92%
Y-mAbs Therapeutics
HHH70.58-4.23
-5.65%
Howard Hughes Holdings
AYTU1.07-0.08
-6.96%
Aytu BioPharma
APP261.98-28.41
-9.78%
Applovin Corp

CPHI and

Correlation & Price change

A.I.dvisor tells us that CPHI and SXTC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPHI and SXTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPHI
1D Price
Change %
CPHI100%
-4.56%
SXTC - CPHI
29%
Poorly correlated
-5.07%
SIGA - CPHI
23%
Poorly correlated
-5.09%
PAHC - CPHI
22%
Poorly correlated
-7.67%
AYTU - CPHI
21%
Poorly correlated
-6.96%
ACB - CPHI
21%
Poorly correlated
-4.03%
More

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
-7.67%
PBH - PAHC
36%
Loosely correlated
-1.72%
SCYX - PAHC
25%
Poorly correlated
-5.20%
IRWD - PAHC
24%
Poorly correlated
-5.56%
EVO - PAHC
24%
Poorly correlated
-0.31%
LFCR - PAHC
23%
Poorly correlated
-5.42%
More